CX-019920: SHINE Mo-99 Commercial Production Project

Provide financial assistance to SHINE Medical Technologies, Inc. to assist in the establishment of the capability to produce at least 3,000 6-day c…

Office of NEPA Policy and Compliance

May 31, 2019
minute read time

Provide financial assistance to SHINE Medical Technologies, Inc. to assist in the establishment of the capability to produce at least 3,000 6-day curies of Molybdenum-99 (Mo-99) per week, steady state, without the use of HEU in the United States as soon as possible.